Missing/wrong data?
Log in to edit
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for eight weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis
scientific article published on 08 May 2020
Author/s
author: Tarik Asselah, Brigitte Chanteranne, Vincent Di Martino, Didier Samuel, Bruno Pereira, Stanislas Pol
Work details
Publication date
May 8, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.